Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Dec 12, 2016 $15.56 $15.79 $15.36 $15.64 121 939
Dec 09, 2016 $16.08 $16.67 $15.56 $15.66 117 767
Dec 08, 2016 $15.39 $16.05 $15.14 $15.91 134 207
Dec 07, 2016 $15.52 $15.72 $14.80 $15.51 178 363
Dec 06, 2016 $15.58 $15.94 $15.10 $15.75 117 979
Dec 05, 2016 $15.67 $15.95 $15.15 $15.54 165 130
Dec 02, 2016 $14.55 $15.94 $14.50 $15.53 123 602
Dec 01, 2016 $15.09 $15.24 $14.31 $14.55 175 949
Nov 30, 2016 $15.20 $15.55 $14.86 $15.00 98 662
Nov 29, 2016 $15.11 $15.58 $14.94 $15.15 123 025
Nov 28, 2016 $15.94 $15.94 $15.08 $15.21 88 140
Nov 25, 2016 $16.05 $16.11 $15.73 $16.01 88 576
Nov 23, 2016 $15.10 $16.08 $14.63 $16.05 118 054
Nov 22, 2016 $15.84 $15.95 $15.16 $15.29 110 837
Nov 21, 2016 $16.01 $16.39 $15.73 $15.81 123 128
Nov 18, 2016 $16.13 $16.14 $15.77 $15.97 73 623
Nov 17, 2016 $16.04 $16.28 $15.86 $16.10 82 014
Nov 16, 2016 $16.01 $16.39 $15.84 $16.07 122 436
Nov 15, 2016 $16.30 $16.44 $15.78 $16.10 145 492
Nov 14, 2016 $16.05 $16.43 $15.60 $16.42 198 878
Nov 11, 2016 $15.90 $16.19 $15.75 $15.94 194 864
Nov 10, 2016 $16.00 $16.45 $15.46 $15.88 210 798
Nov 09, 2016 $14.80 $15.94 $14.80 $15.69 260 402
Nov 08, 2016 $14.49 $14.49 $14.49 $14.49 137 707
Nov 07, 2016 $14.26 $14.26 $14.26 $14.26 136 100
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT